Atlas Trials

Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone

Clinical trial NCT03742063 · COMPLETED

Trial details

NCT number
NCT03742063
Sponsor
Peking University People's Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Clinical ResponseHistopathological ResponsePrognosis
Start date
2017-06-01
Primary completion
2017-12-31
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.